Randomized Control Trial Evaluating the Impact of CGM Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 1 Diabetes
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- Mean change in Hemoglobin A1c from baseline to 6 months
研究概览
简要总结
The goal of this randomized clinical trial is to compare the effects of a virtual education curriculum in blood glucose variation of youth with type 1 diabetes wearing continuous glucose monitoring (CGM) device. The main questions the study aims to answer are:
- Do participants undertaking the proposed curriculum present improved glucose variation than participants of standard education?
- Explore relationships between participant's glycemic outcomes with diabetes distress, diabetes family responsibilities, and number of hours of diabetes education.
Participants in the intervention group will:
- receive an interactive workbook with problem-based learning scenarios and video links about CGM and glucose management strategies.
- participate in four in-depth online group sessions with diabetes care and education specialists
- complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.
Participants in the comparison group will:
- receive standard education provided to all patients at CHLA
- complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.
详细描述
Youth with type 1 diabetes (T1D) are at increased risk for kidney failure, vision loss, heart disease, and premature mortality due to challenges with glycemic excursions. Continuous glucose monitoring (CGM) systems represent an important advance in diabetes technology with significant advantages over self-monitored blood glucose and the potential to optimize glycemic management. Despite these advances, youth with T1D, including patients at Children's Hospital Los Angeles (CHLA), fail to achieve recommended glycemic targets, highlighting the opportunity for testing innovative diabetes education programs aimed at increased technology uptake such as the CGM Academy intervention.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
盲法说明
Everyone will know their assigned intervention.
入排标准
- 年龄范围
- 8 Years 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Current age of 8-18 years, age group eligible for CGM therapy with Dexcom G6 and G7
- •T1D duration ≥6 months, as insulin adjustments during honeymoon stage differs from establishedT1D
- •Able to speak, read, and write English or Spanish
- •Smartphone compatible with Dexcom G6 and G7application
- •Ability to participate in virtual visits
排除标准
- •Known history of medical adhesive allergies
研究组 & 干预措施
CGM Academy
- receive an interactive workbook with problem-based learning scenarios and video links about CGM and glucose management strategies.
- participate in four in-depth online group sessions with diabetes care and education specialists
- complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.
干预措施: CGM Academy (Behavioral)
Standard Diabetes Education
- receive standard education provided to all patients at CHLA
- complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.
结局指标
主要结局
Mean change in Hemoglobin A1c from baseline to 6 months
时间窗: Baseline to 6 months
Change in Hemoglobin A1c
次要结局
- Mean change in HbA1c (%) from baseline to 6 months.(Baseline to 6 months)
- Mean change in CGM metrics measured by CGM readings(Week 4 & 6 months)
- Change in perceived diabetes distress at baseline, week 4 & 6 months(Baseline, Week 4 & 6 months)
- Change in perceived diabetes family responsibility at baseline, week 4 & 6 months.(Baseline, week 4 & 6 months)
- Average number of diabetes educator hours used per study participant at week 4 & 6 months.(Week 4 and 6 months)
- Perceived benefits of Continuous Glucose Monitor (CGM) use(week 4 & 6 months)
- Perceived burden of Continuous Glucose Monitor (CGM) use(week 4 & 6 months)
研究者
Barber, Rebecca
Principal Investigator
Children's Hospital Los Angeles